← Back to Screener
Dermata Therapeutics, Inc. Warrant (DRMAW)
Price$0.01
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-44.88%
Price vs S&P 500 (4W)-27.91%
VGM Score24.87
All Metrics
Price vs S&P 500 (YTD)-52.98%
10-Day Avg Trading Volume0.01M
3-Month Avg Trading Volume0.01M
52-Week High$0.03
26-Week Price Return-31.00%
13-Week Price Return-36.11%
3-Month Return Std Dev195.37%
Year-to-Date Return-42.74%
5-Day Price Return0.73%
Month-to-Date Return-8.00%
Price vs S&P 500 (13W)-44.98%
Beta1.45x
52-Week Low$0.01
mGradeD
vgmGradeD
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
DRMAWDermata Therapeutics, Inc. Warrant | — | — | D | $0.01 |
| LLYEli Lilly & Co. | D | B | B | $1082.20 |
| JNJJohnson & Johnson | C | C | C | $223.51 |
| ABBVABBVIE INC. | D | C | C | $212.93 |
| MRKMerck & Co., Inc. | C | C | C | $115.17 |
| NVSNovartis AG | C | C | C | $145.68 |
| AZNAstraZeneca PLC | D | B | C | $179.71 |
| NVONovo-Nordisk A/S | B | B | C | $44.07 |
| ABTAbbott Laboratories | C | C | D | $87.78 |
| PFEPfizer Inc. | B | C | C | $25.63 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $34.64 |
About
Dermata Therapeutics develops over-the-counter dermatology products for acne, psoriasis, rosacea, and seborrheic dermatitis. The company is advancing a once-weekly acne treatment combining an OTC-approved active ingredient with its proprietary Spongilla delivery technology. Dermata intends to expand the Spongilla platform across multiple dermatologic and aesthetic applications, including intradermal botulinum toxin delivery.